Vical to Present at the 27th Annual ROTH Conference
Get Alerts VICL Hot Sheet
Join SI Premium – FREE
SAN DIEGO, March 5, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on Wednesday, March 11, at 11:30 a.m. PDT at the ROTH Capital Partners 27th Annual ROTH Conference (Newport Beach, California March 8 – 11). A webcast of the company's presentation will be available live and archived through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.
About Vical
Vical researches and develops biopharmaceutical products leveraging its patented DNA delivery technologies for the prevention and treatment of chronic or life-threatening infectious diseases. In addition, the company has collaborations with major pharmaceutical and biotechnology companies focused on addressing significant unmet medical needs. Additional information on Vical is available at www.vical.com.
CONTACT: Andrew Hopkins (858) 646-1127 Website: www.vical.comSource: Vical Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Back Discomfort Hits Just Above the Belt, According to Life Extension Survey
- Sibel Health awarded a major grant to advance maternal monitoring solution for low-and-middle income countries.
- 4D Printing in Healthcare Market Size Worth USD 16.31, Globally, by 2030 – Exclusive Report by SNS INSIDER
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!